Case number 2024-2002
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 29, 2024 | 18 | ORDER filed; Samsung's motion [1023556-2] is granted only to the extent that Appeal Nos. 2024-1965 et al. and 2024-2009 et al. are designated companion cases and, separately, Appeal Nos. 2024-2002 and 2024-2058 are designated companion cases. The Clerk of Court shall transmit a copy of this order to the merits panels for these appeals. (Per Curiam). Service as of this date by the Clerk of Court. [1028863] [24-1965, 24-2002, 24-2009, 24-2058] [NL] [Entered: 08/29/2024 02:56 PM] (5) |
| Aug 21, 2024 | 16 | MODIFIED ENTRY: CONFIDENTIAL OPENING BRIEF FILED by Appellants Biocon Biologics Inc. and Mylan Pharmaceuticals Inc.. Service: 08/21/2024 by email. [1026883]--[Edited 08/26/2024 by JSP - compliance review complete] [Deanne Mazzochi] [Entered: 08/21/2024 06:12 PM] (0) |
| Aug 21, 2024 | 17 | MODIFIED ENTRY: OPENING BRIEF FILED by Appellants Biocon Biologics Inc. and Mylan Pharmaceuticals Inc.. Service: 08/21/2024 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [1026884] --[Edited 08/26/2024 by JSP - compliance review complete] [Deanne Mazzochi] [Entered: 08/21/2024 06:15 PM] (524) |
| Jul 24, 2024 | 15 | ORDER The motion to expedite [6] is granted only to the extent that the court will place the appeals together on the next available oral argument calendar once briefing is completed. No extensions of time for the briefs should be anticipated. Consolidated Appeal Nos. 2024-1965 and 2024-1966; Appeal No. 2024-2002; consolidated Appeal Nos. 2024-2009 and 2024-2019; and Appeal No. 2024-2058 shall be considered companion cases and assigned to the same merits panel. The Clerk of Court shall transmit a copy of this order to the merits panel. Service as of this date by the Clerk of Court. [1020179] [NL] [Entered: 07/24/2024 09:53 AM] (5) |
| Jul 8, 2024 | 13 | REPLY of Appellants Biocon Biologics Inc. and Mylan Pharmaceuticals Inc. to response [12]. Service: 07/08/2024 by email. [1016211] [24-2002] [William Rakoczy] [Entered: 07/08/2024 06:37 PM] (19) |
| Jul 8, 2024 | 14 | Certificate of Compliance with Fed. R. App. P. 10(b) [The Transcript of Proceedings] for Appellants Biocon Biologics Inc. and Mylan Pharmaceuticals Inc.. Service: 07/08/2024 by email. [1016212] [24-2002] [William Rakoczy] [Entered: 07/08/2024 06:47 PM] (2) |
| Jul 5, 2024 | 8 | Entry of Appearance for David I. Berl; Thomas S. Fletcher; Andrew V. Trask; Shaun P. Mahaffy; Kathryn S. Kayali; Arthur J. Argall III; Adam Pan; Christian Gladden-Sorensen; Rhochelle Krawetz; Elizabeth S. Weiswasser; Priyata Patel; Jacob E. Hartman as counsel for Appellee Regeneron Pharmaceuticals, Inc.. Service: 07/05/2024 by email. [1015813] [24-2002] [David Berl] [Entered: 07/05/2024 05:28 PM] (3) |
| Jul 5, 2024 | 9 | Docketing Statement for the Appellee Regeneron Pharmaceuticals, Inc.. Service: 07/05/2024 by email. [1015815] [24-2002] [David Berl] [Entered: 07/05/2024 05:31 PM] (2) |
| Jul 5, 2024 | 10 | Certificate of Interest for Appellee Regeneron Pharmaceuticals, Inc.. Service: 07/05/2024 by email. [1015816] [24-2002] [David Berl] [Entered: 07/05/2024 05:36 PM] (4) |
| Jul 5, 2024 | 11 | Notice of Related Case Information for Appellee Regeneron Pharmaceuticals, Inc.. Service: 07/05/2024 by email. [1015818] [24-2002] [David Berl] [Entered: 07/05/2024 05:38 PM] (4) |
| Jul 5, 2024 | 12 | RESPONSE of Appellee Regeneron Pharmaceuticals, Inc. to Doc No. [6], [6]. Service: 07/05/2024 by email. [1015819] [24-2002] [David Berl] [Entered: 07/05/2024 05:48 PM] (35) |
| Jun 28, 2024 | 7 | ORDER Any opposition to the motion [6] is due no later than July 5, 2024. Any reply in support of the motion is due no later than July 8, 2024. Service as of this date by the Clerk of Court. [NL] [Entered: 06/28/2024 12:24 PM] (2) |
| Jun 27, 2024 | 2 | Certificate of Interest for Appellants Biocon Biologics Inc. and Mylan Pharmaceuticals Inc.. Service: 06/27/2024 by email. [1014126] [24-2002] [Deanne Mazzochi] [Entered: 06/27/2024 10:05 PM] (5) |
| Jun 27, 2024 | 3 | Docketing Statement for the Appellants Biocon Biologics Inc. and Mylan Pharmaceuticals Inc.. Service: 06/27/2024 by email. [1014128] [24-2002] [William Rakoczy] [Entered: 06/27/2024 10:16 PM] (2) |
| Jun 27, 2024 | 4 | Notice of Related Case Information for Appellants Biocon Biologics Inc. and Mylan Pharmaceuticals Inc.. Service: 06/27/2024 by email. [1014129] [24-2002] [William Rakoczy] [Entered: 06/27/2024 10:19 PM] (6) |
| Jun 27, 2024 | 5 | Entry of Appearance for William A. Rakoczy; Heinz J. Salmen; Paul J. Molino; Deanne M. Mazzochi; Eric R. Hunt; Lauren M. Lesko; Neil B. McLaughlin as counsel for Appellants Biocon Biologics Inc. and Mylan Pharmaceuticals Inc.. Service: 06/27/2024 by email. [1014132] [24-2002] [William Rakoczy] [Entered: 06/27/2024 10:28 PM] (2) |
| Jun 27, 2024 | 6 | MOTION of Appellants Biocon Biologics Inc. and Mylan Pharmaceuticals Inc. to expedite briefing schedule, to expedite hearing. Service: 06/27/2024 by email. [1014133] [24-2002] [William Rakoczy] [Entered: 06/27/2024 10:38 PM] (19) |
| Jun 25, 2024 | 1 | Appeal docketed. Received: 06/21/2024. [1013376]Entry of Appearance is due on 07/09/2024. Certificate of Interest is due on 07/09/2024. Docketing Statement is due on 07/09/2024. Appellants' brief is due on 08/26/2024. [JSP] [Entered: 06/25/2024 02:59 PM] (69) |
